Events & Presentations

Ablynx organises webcasts for analysts and investors on the occasion of financial results publications and product specific news. In addition, the Company’s presentations at investor conferences are often webcasted and made available for the broader public.

Upcoming IR Events

Ablynx will announce its 2017 half year financial results with webcast
Thursday 24 August 2017 at 4.00 pm CET/10.00 am ET

Visit event

J.P. Morgan Small/Mid-Cap Conference
12-14 September 2017 - London, UK

Annual BAML Healthcare Conference
13-15 September 2017 - London, UK

Annual KBC Healthcare Conference
28 September 2017 - New York, USA

VFB Dag Van de Tips
30 September 2017 - Gent, Belgium

Recent IR Presentations

Jefferies 2017 Global Healthcare Conference
6-9 June 2017 - New York, USA - Webcast on 6 June at 11.30 a.m. EST

Click here to replay the webcast

pdf version of the presentation

UBS Global Healthcare Conference
22-24 May 2017 - New York, USA

pdf version of the presentation

Ablynx's 2016 full year results webcast
23 February 2017

Click here to replay the webcast

pdf version of the presentation

Webcast presentatie - vobarilizumab, a novel best-in-class anti-IL-6R drug candidate for the treatment of RA
20 oktober 2016

Click here to replay the webcast

pdf version of the presentation

Upcoming Scientific Events

5th Annual Immuno-Oncology Summit
28 August-1 September 2017 - Boston (MA), USA

10th Annual Bioassay Conference (BEPBA)
27-29 September 2017 - St. Julians, Malta

Recent Scientific Presentations

Poster "Results of a Phase 2b Study of Vobarilizumab, an Anti-Interleukin 6 Receptor Nanobody®, as Monotherapy in Patients with Moderate-to-Severe Rheumatoid Arthritis" presented at the European Congress of Rheumatology (EULAR)
14-17 June 2017 - Madrid, Spain

pdf version of the presentation

Presentation "Remission and Maintenance of Efficacy in a Phase 2b study of Vobarilizumab, an Anti-Interleukin 6 Receptor Nanobody®, in Patients with Moderate-to-Severe Rheumatoid Arthritis despite Treatment with Methotrexateat" presented at the European Congress of Rheumatology (EULAR)
14-17 June 2017 - Madrid, Spain

pdf version of the presentation

Poster "Impact of caplacizumab treatment on mortality and major thromboembolic events in acquired TTP: Phase II TITAN study results" presented at the 21st European Hemathology Association Congress
9 June 2016 - Copenhagen, Denmark

pdf version of the presentation

Nanobodies as a Versatile Approach for Developing Next Generation Immunotherapies
26 January 2016 - Washington (DC), USA

pdf version of the presentation

Shareholders' Clubs
at
Ablynx

Individual investors can meet with the Ablynx management team at Ablynx’s Quarterly Shareholders’ Clubs organised at Ablynx.

The next events in Dutch will take place on:

5 October 2017 at 5.30pm
6 December 2017 at 5.30pm

To attend an event, please register via email: investors@ablynx.com, mentioning your name and preferred day.

Please click here to download the presentation of the most recent shareholders' club.